[1]Hope WW, Petraitis V, Petraitiene R,et al. The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1→3) β-d-glucan and consequences of delayed antifungal therapy[J]. Antimicrob Agents Chemother, 2010,54(11):4879-4886.
[2]Koo S, Bryar JM, Page JH, et al. Diagnostic performance of the (1→3)-beta-D-glucan assay for invasive fungal disease[J]. Clin Infect Dis,2009,49(11):1650-1659.
[3]刘佳庆,张丽霞,刘 雅,等.(1,3 )-β-D葡聚糖在侵袭性肺部真菌感染的诊断价值[J]. 中国医学检验杂志,2010,11(1):10-12.
[4]Metan G, Agkus C, Buldu H, et al. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections[J]. Infection,2010,38(3):217-221.
[5]Koo S, Bryar JM, Page JH, et al. Diagnostic performance of the (1→3)-beta-D-glucan assay for invasive fungal disease[J]. Clin Infect Dis,2009,9(11):1650-1659.
[6]Jia W,Li YC,Zhu YQ,et al. The clinical efficacy and cardiac safety of itraconazole injection in treatment of acute pulmonary invasive fungal infection in chronic pulmonary diseases in the elderly[J].Zhonghua Nei Ke Za Zhi,2010,49(3):230-233.
[7]杨 芳,魏宗赛, 叶小兰. 某医院深部真菌感染调查分析[J]. 东南国防医药,2009,11(5):423-424.
[8]Guery BP, Arendrup MC, Auzinger G,et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis[J]. Intensive Care Med,2009,35(1):55-62.
[9]Del Palacio A, Cuétara MS, Llenas-García J, et al. Serum (1→3)-{beta}-D-Glucan assay for the diagnosis of Pneumocystis jiroveci pneumonia[J]. Clin Vaccine Immunol,2010,17(1):202-203.
[10]Racil Z, Kocmanova I, Lengerova M, et al. Difficulties in using 1,3-{beta}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies-high frequency of false-positive results and their analysis[J].J Med Microbiol,2010,59(9):1016-1022.